These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 1334113
21. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. Koshiyama M, Fujii H, Kinezaki M, Morita Y, Nanno H, Yoshida M. Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788 [Abstract] [Full Text] [Related]
22. [Sensitivity testing of anticancer drugs using the human tumor clonogenic assay]. Hiraki S, Ohnoshi T, Kishimoto N, Mori K, Nishii K, Yonei T, Yamashita H, Kimura I. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1208-13. PubMed ID: 3729443 [Abstract] [Full Text] [Related]
23. Human tumor colony assay and chemosensitivity testing. Salmon SE. Cancer Treat Rep; 1984 Jan; 68(1):117-25. PubMed ID: 6692423 [Abstract] [Full Text] [Related]
24. [In vitro chemosensitivity assay using a double-layer-agar system: human tumor cloning assay and thymidine incorporation assay]. Tanigawa N, Shimomatsuya T, Fujii H, Yamakawa M, Muraoka R, Saitoh H. Gan To Kagaku Ryoho; 1993 Mar; 20(4):440-6. PubMed ID: 8452381 [Abstract] [Full Text] [Related]
25. Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells. Lage H, Dietel M. J Cancer Res Clin Oncol; 2002 Jul; 128(7):349-57. PubMed ID: 12136248 [Abstract] [Full Text] [Related]
26. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G. Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085 [Abstract] [Full Text] [Related]
27. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype. Matsumoto Y, Takano H, Fojo T. Cancer Res; 1997 Nov 15; 57(22):5086-92. PubMed ID: 9371507 [Abstract] [Full Text] [Related]
28. Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay. Ali-Osman F, Giblin J, Dougherty D, Rosenblum ML. Cancer Res; 1987 Jul 15; 47(14):3718-24. PubMed ID: 2954633 [Abstract] [Full Text] [Related]
29. In vitro assays of chemotherapeutic sensitivity. Carney DN, Winkler CF. Important Adv Oncol; 1985 Jul 15; ():78-103. PubMed ID: 3916747 [Abstract] [Full Text] [Related]
30. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Brown GA, McPherson JP, Gu L, Hedley DW, Toso R, Deuchars KL, Freedman MH, Goldenberg GJ. Cancer Res; 1995 Jan 01; 55(1):78-82. PubMed ID: 7805045 [Abstract] [Full Text] [Related]
31. The human tumor stem cell assay revisited. Singletary SE, Umbach GE, Spitzer G, Drewinko B, Tomasovic B, Ajani J, Hug V, Blumenschein G. Int J Cell Cloning; 1985 Mar 01; 3(2):116-28. PubMed ID: 3998518 [Abstract] [Full Text] [Related]
32. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene. Lorico A, Rappa G, Srimatkandada S, Catapano CV, Fernandes DJ, Germino JF, Sartorelli AC. Cancer Res; 1995 Oct 01; 55(19):4352-60. PubMed ID: 7671247 [Abstract] [Full Text] [Related]
33. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids. Moritaka T, Kiura K, Ueoka H, Tabata M, Segawa Y, Shibayama T, Takigawa N, Ohnoshi T, Harada M. Anticancer Res; 1998 Oct 01; 18(2A):927-33. PubMed ID: 9615743 [Abstract] [Full Text] [Related]
34. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II. Campain JA, Padmanabhan R, Hwang J, Gottesman MM, Pastan I. J Cell Physiol; 1993 May 01; 155(2):414-25. PubMed ID: 8097746 [Abstract] [Full Text] [Related]
35. What's new in cytostatic drug resistance and pathology. Dietel M. Pathol Res Pract; 1991 Sep 01; 187(7):892-905. PubMed ID: 1754514 [Abstract] [Full Text] [Related]
36. [Ex-vivo-chemoresponse testing of head and neck cancer: an old hat?]. Wichmann G, Körner C, Dietz A. Laryngorhinootologie; 2011 Aug 01; 90(8):464-8. PubMed ID: 21809229 [Abstract] [Full Text] [Related]
37. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancers, measured by the human tumor clonogenic assay. Murakami A, Koga S, Maeta M. Oncology; 1988 Aug 01; 45(3):236-41. PubMed ID: 3368200 [Abstract] [Full Text] [Related]
38. Human tumor clonogenic assay in patients with unknown primary carcinomas. Greenberg BR, Salmon SE. J Clin Oncol; 1984 Jan 01; 2(1):46-50. PubMed ID: 6699658 [Abstract] [Full Text] [Related]
39. In vitro chemosensitivity patterns of carcinoma of the lung in human tumor clonogenic assay. Kanzawa F, Matsushima Y, Ishihara J, Shimizu E, Sasaki Y, Eguchi K, Shinkai T, Saijo N, Miyazawa N, Hamburger AW. J Pharmacobiodyn; 1986 Sep 01; 9(9):715-21. PubMed ID: 3794992 [Abstract] [Full Text] [Related]
40. Human tumor clonogenic assay in osteosarcoma for evaluation of clinical efficacy of anti-cancer drugs. Tomita K, Yokogawa A, Nomura S. Cancer Chemother Pharmacol; 1986 Sep 01; 18(2):133-6. PubMed ID: 3466725 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]